MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1

被引:24
作者
Balasubramanian, Karthika [1 ]
Li, Bing [1 ]
Krakow, Deborah [2 ,3 ,4 ]
Nevarez, Lisette [1 ]
Ho, Patric J. [1 ]
Ainsworth, Julia A. [1 ]
Nickerson, Deborah A. [5 ]
Bamshad, Michael J. [5 ,6 ]
Immken, LaDonna [7 ]
Lachman, Ralph S. [4 ]
Cohn, Daniel H. [1 ,2 ,4 ]
机构
[1] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Int Skeletal Dysplasia Registry, Los Angeles, CA USA
[5] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[6] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[7] Specially Children Genet, Austin, TX USA
关键词
CANT1; chondrodysplasia; desbuquois dysplasia; multiple epiphyseal dysplasia; skeletal dysplasia; MULTIPLE EPIPHYSEAL DYSPLASIA; DESBUQUOIS DYSPLASIA; SULFATE TRANSPORTER; CARTILAGE; DOMAIN; COMP; PSEUDOACHONDROPLASIA; FRAMEWORK; COLLAGEN; PROTEIN;
D O I
10.1002/ajmg.a.38349
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Multiple Epiphyseal Dysplasia (MED) is a relatively mild skeletal dysplasia characterized by mild short stature, joint pain, and early-onset osteoarthropathy. Dominantly inherited mutations in COMP, MATN3, COL9A1, COL9A2, and COL9A3, and recessively inherited mutations in SLC26A2, account for the molecular basis of disease in about 80-85% of the cases. In two families with recurrent MED of an unknown molecular basis, we used exome sequencing and candidate gene analysis to identify homozygosity for recessively inherited missense mutations in CANT1, which encodes calcium-activated nucleotidase 1. The MED phenotype is thus allelic to the more severe Desbuquois dysplasia phenotype and the results identify CANT1 as a second locus for recessively inherited MED.
引用
收藏
页码:2415 / 2421
页数:7
相关论文
共 35 条
  • [1] A method and server for predicting damaging missense mutations
    Adzhubei, Ivan A.
    Schmidt, Steffen
    Peshkin, Leonid
    Ramensky, Vasily E.
    Gerasimova, Anna
    Bork, Peer
    Kondrashov, Alexey S.
    Sunyaev, Shamil R.
    [J]. NATURE METHODS, 2010, 7 (04) : 248 - 249
  • [2] Combined Role of Type IX Collagen and Cartilage Oligomeric Matrix Protein in Cartilage Matrix Assembly Cartilage Oligomeric Matrix Protein Counteracts Type IX Collagen-Induced Limitation of Cartilage Collagen Fibril Growth in Mouse Chondrocyte Cultures
    Blumbach, K.
    Bastiaansen-Jenniskens, Y. M.
    DeGroot, J.
    Paulsson, M.
    van Osch, G. J. V. M.
    Zaucke, F.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (12): : 3676 - 3685
  • [3] Ablation of collagen IX and COMP disrupts epiphyseal cartilage architecture
    Blumbach, Katrin
    Niehoff, Anja
    Paulsson, Mats
    Zaucke, Frank
    [J]. MATRIX BIOLOGY, 2008, 27 (04) : 306 - 318
  • [4] Bonafe L., 2002, GENEREVIEWS SEATTLE
  • [5] Briggs M. D., 2003, GENEREVIEWS SEATTLE
  • [6] COMP mutations: Domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes
    Chen, Tung-Ling L.
    Posey, Karen L.
    Hecht, Jacqueline T.
    Vertel, Barbara M.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (03) : 778 - 787
  • [7] Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3
    Cotterill, SL
    Jackson, GC
    Leighton, MR
    Wagener, R
    Mäkitie, O
    Cole, WG
    Briggs, MD
    [J]. HUMAN MUTATION, 2005, 26 (06) : 557 - 565
  • [8] A founder mutation of CANT1 common in Korean and Japanese Desbuquois dysplasia
    Dai, Jin
    Kim, Ok-Hwa
    Cho, Tae-Joon
    Miyake, Noriko
    Song, Hae-Ryong
    Karasugi, Tatsuki
    Sakazume, Satoru
    Ikema, Masahide
    Matsui, Yoshito
    Nagai, Toshiro
    Matsumoto, Naomichi
    Ohashi, Hirofumi
    Kamatani, Naoyuki
    Nishimura, Gen
    Furuichi, Tatsuya
    Takahashi, Atsushi
    Ikegawa, Shiro
    [J]. JOURNAL OF HUMAN GENETICS, 2011, 56 (05) : 398 - 400
  • [9] Structure and protein design of a human platelet function inhibitor (vol 116, pg 649, 2004)
    Dai, JY
    Liu, J
    Deng, YQ
    Smith, TM
    Lu, M
    [J]. CELL, 2004, 117 (03) : 413 - 413
  • [10] Desbuquois dysplasia, a reevaluation with abnormal and "normal" hands: Radiographic manifestations
    Faivre, L
    Cormier-Daire, V
    Eliott, AM
    Field, F
    Munnich, A
    Maroteaux, P
    Le Merrer, M
    Lachman, R
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 124A (01): : 48 - 53